Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P11177
UPID:
ODPB_HUMAN
Alternative names:
-
Alternative UPACC:
P11177; B2R7L0; B4DDD7; Q6FH45; Q9BQ27; Q9UFK3
Background:
The Pyruvate dehydrogenase E1 component subunit beta, mitochondrial, encoded by the P11177 gene, plays a pivotal role in cellular energy metabolism. It facilitates the conversion of pyruvate to acetyl-CoA and CO2, bridging the glycolytic pathway with the tricarboxylic cycle, essential for ATP production.
Therapeutic significance:
Pyruvate dehydrogenase E1-beta deficiency, a disease linked to this protein, manifests as primary lactic acidosis in children, with symptoms ranging from fatal lactic acidosis in newborns to chronic neurological dysfunction. Understanding the role of this protein could lead to novel therapeutic strategies for managing this condition.